Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
250
-
Total 13F shares, excl. options
-
67.9M
-
Shares change
-
+3.01M
-
Total reported value, excl. options
-
$2.87B
-
Value change
-
+$110M
-
Put/Call ratio
-
5.32
-
Number of buys
-
126
-
Number of sells
-
-123
-
Price
-
$42.30
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q2 2019
301 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q2 2019.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 250 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.9M shares
of 115M outstanding shares and own 58.91% of the company stock.
Largest 10 shareholders include BlackRock Inc. (9.63M shares), VANGUARD GROUP INC (7.18M shares), JANUS HENDERSON GROUP PLC (6.18M shares), WELLINGTON MANAGEMENT GROUP LLP (4.37M shares), STATE STREET CORP (2.63M shares), AQR CAPITAL MANAGEMENT LLC (2M shares), Van Berkom & Associates Inc. (1.48M shares), Standard Life Aberdeen plc (1.42M shares), Investec Asset Management LTD (1.36M shares), and MANUFACTURERS LIFE INSURANCE COMPANY, THE (1.34M shares).
This table shows the top 250 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.